279 related articles for article (PubMed ID: 20562919)
1. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression.
Shimura T; Kakuda S; Ochiai Y; Nakagawa H; Kuwahara Y; Takai Y; Kobayashi J; Komatsu K; Fukumoto M
Oncogene; 2010 Aug; 29(34):4826-37. PubMed ID: 20562919
[TBL] [Abstract][Full Text] [Related]
2. Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle.
Shimura T
J Radiat Res; 2011; 52(5):539-44. PubMed ID: 21881296
[TBL] [Abstract][Full Text] [Related]
3. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells.
Shimura T; Ochiai Y; Noma N; Oikawa T; Sano Y; Fukumoto M
Cell Cycle; 2013 Mar; 12(5):773-82. PubMed ID: 23388457
[TBL] [Abstract][Full Text] [Related]
5. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
6. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.
Ramljak D; Calvert RJ; Wiesenfeld PW; Diwan BA; Catipovic B; Marasas WF; Victor TC; Anderson LM; Gelderblom WC
Carcinogenesis; 2000 Aug; 21(8):1537-46. PubMed ID: 10910956
[TBL] [Abstract][Full Text] [Related]
7. Targeting the AKT/cyclin D1 pathway to overcome intrinsic and acquired radioresistance of tumors for effective radiotherapy.
Shimura T
Int J Radiat Biol; 2017 Apr; 93(4):381-385. PubMed ID: 27910734
[TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X
Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000
[TBL] [Abstract][Full Text] [Related]
9. HBx protein modulates PI3K/Akt pathway to overcome genotoxic stress-induced destabilization of cyclin D1 and arrest of cell cycle.
Mukherji A; Janbandhu VC; Kumar V
Indian J Biochem Biophys; 2009 Feb; 46(1):37-44. PubMed ID: 19374252
[TBL] [Abstract][Full Text] [Related]
10. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
[TBL] [Abstract][Full Text] [Related]
12. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.
Takahashi-Yanaga F; Sasaguri T
Cell Signal; 2008 Apr; 20(4):581-9. PubMed ID: 18023328
[TBL] [Abstract][Full Text] [Related]
13. GSK-3beta-dependent destabilization of cyclin D1 mediates replicational stress-induced arrest of cell cycle.
Mukherji A; Janbandhu VC; Kumar V
FEBS Lett; 2008 Apr; 582(7):1111-6. PubMed ID: 18328826
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
Liu L; Zhang H; Shi L; Zhang W; Yuan J; Chen X; Liu J; Zhang Y; Wang Z
Oncol Rep; 2014 Oct; 32(4):1395-400. PubMed ID: 25109327
[TBL] [Abstract][Full Text] [Related]
15. Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells.
Yu XJ; Han QB; Wen ZS; Ma L; Gao J; Zhou GB
Cancer Lett; 2012 Sep; 322(2):185-94. PubMed ID: 22410463
[TBL] [Abstract][Full Text] [Related]
16. Ophiobolin O isolated from Aspergillus ustus induces G1 arrest of MCF-7 cells through interaction with AKT/GSK3β/cyclin D1 signaling.
Lv C; Qin W; Zhu T; Wei S; Hong K; Zhu W; Chen R; Huang C
Mar Drugs; 2015 Jan; 13(1):431-43. PubMed ID: 25603341
[TBL] [Abstract][Full Text] [Related]
17. GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients.
Quintayo MA; Munro AF; Thomas J; Kunkler IH; Jack W; Kerr GR; Dixon JM; Chetty U; Bartlett JM
Breast Cancer Res Treat; 2012 Nov; 136(1):161-8. PubMed ID: 22976805
[TBL] [Abstract][Full Text] [Related]
18. The double dealing of cyclin D1.
Tchakarska G; Sola B
Cell Cycle; 2020 Jan; 19(2):163-178. PubMed ID: 31885322
[TBL] [Abstract][Full Text] [Related]
19. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
